Engen bio

Crowdfunding Campaign: Messaging strategy and execution nets $1.2M

EnGen Bio had the science and technology to develop universal vaccines for the flu and other infectious diseases — a transformative platform counter to big pharma’s seasonal approach, which lacks true effectiveness and depends on production methods that are unsustainable. Instead of pursuing venture capital investment, EnGen Bio wanted support in leveraging the increased awareness created by COVID to attract investors from non-traditional sources.
engenbio.com

  • Core language & identity

  • Content strategy & development

  • Investor communications

  • Website

  • Collateral assets

  • Art Direction

  • Project management